Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

SNDX holding history

Syndax Pharmaceuticals Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SNDX overviewAll 13F holders of SNDXFull Q2 2026 holdings

Shares (Q2 2026)
1,239,954
Value
$27.1M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of SNDX by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,239,954$27.1M<0.1%−361,942−22.6%ReducedHolders
Q1 20261,601,896$37.4M<0.1%+382,287+31.3%AddedHolders
Q4 20251,219,609$25.6M<0.1%+142,024+13.2%AddedHolders
Q3 20251,077,585$16.6M<0.1%+433,043+67.2%AddedHolders
Q2 2025644,542$6.04M<0.1%−143,045−18.2%ReducedHolders
Q1 2025787,587$9.68M<0.1%+603,470+327.8%AddedHolders
Q4 2024184,117$2.43M<0.1%−168,241−47.7%ReducedHolders
Q3 2024352,358$6.78M<0.1%+205,715+140.3%AddedHolders
Q2 2024146,643$3.01M<0.1%+138,119+1,620.4%AddedHolders
Q1 20248,524$202.9K<0.1%−33,441−79.7%ReducedHolders
Q4 202341,965$906.9K<0.1%−106,607−71.8%ReducedHolders
Q3 2023148,572$2.16M<0.1%−24,447−14.1%ReducedHolders
Q2 2023173,019$3.62M<0.1%+33,952+24.4%AddedHolders
Q1 2023139,067$2.94M<0.1%−21,368−13.3%ReducedHolders
Q4 2022160,435$4.08M<0.1%+32,407+25.3%AddedHolders
Q3 2022128,028$3.08M<0.1%+128,028NewHolders
Q1 20220$00.0%−123,303−100.0%Sold outHolders
Q4 2021123,303$2.70M<0.1%−213,843−63.4%ReducedHolders
Q3 2021337,146$6.44M<0.1%−73,321−17.9%ReducedHolders
Q2 2021410,467$7.05M<0.1%−163,471−28.5%ReducedHolders
Q1 2021573,938$12.8M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.